Importantly, the group generated a CD19 knockout tumor model by CRISPR/Cas9 and showed that CD19 CAR-Vγ9Vδ2 T cells in the presence of ZOL had enhanced cytotoxicity against CD19- tumor cells compared to conventional CD19-CAR T cells. Here, CD19 is linked to neoplasm.